Table 1.
Mortality rates in study participants with valid information on vital status on October 31 2015, stratified by quartiles of triglycerides, HDL cholesterol, and TG:HDL
| N | Events | Percent events | Events per 1000 patient-years (95% CI), unadjusted | p | Events per 1000 patient-years (95% CI), age- & gender-adjusted | p | |
|---|---|---|---|---|---|---|---|
| Triglycerides | 0.666 | < 0.0001 | |||||
| I | 3992 | 897 | 22.5 | 30.25 (28.33–32.29) | Ref | 11.02 (9.60–12.64) | Ref |
| II | 3839 | 886 | 23.1 | 31.09 (29.11–33.20) | 0.563 | 11.82 (10.35–13.50) | 0.138 |
| III | 3933 | 929 | 23.6 | 32.03 (30.03–34.15) | 0.222 | 12.76 (11.20–14.54) | 0.002 |
| IV | 3892 | 890 | 22.9 | 30.76 (28.80–32.85) | 0.722 | 14.10 (12.39–16.05) | < 0.0001 |
| HDL cholesterol | < 0.0001 | < 0.0001 | |||||
| I | 4025 | 1061 | 26.4 | 36.53 (34.39–38.79) | < 0.0001 | 18.16 (15.81–20.86) | < 0.0001 |
| II | 3982 | 881 | 22.1 | 29.68 (27.78–31.70) | 0.566 | 13.68 (11.94–15.68) | 0.008 |
| III | 3769 | 818 | 21.7 | 29.01 (27.09–31.07) | 0.921 | 12.55 (10.98–14.36) | 0.392 |
| IV | 3880 | 842 | 21.7 | 28.87 (26.98–30.88) | Ref | 12.03 (10.60–13.66) | Ref |
| TG:HDL | 0.056 | < 0.0001 | |||||
| I | 3914 | 863 | 22.1 | 29.48 (27.58–31.51) | Ref | 11.02 (9.65–12.59) | Ref |
| II | 3916 | 869 | 22.2 | 29.79 (27.87–31.83) | 0.829 | 11.83 (10.36–13.50) | 0.143 |
| III | 3915 | 927 | 23.7 | 32.12 (30.12–34.25) | 0.070 | 13.18 (11.56–15.03) | < 0.0001 |
| IV | 3911 | 943 | 24.1 | 32.76 (30.73–34.91) | 0.025 | 15.51 (13.60–17.70) | < 0.0001 |
TG:HDL triglyceride:HDL cholesterol ratio, CI confidence interval